The relationship between angiotensinconverting enzyme (ACE) gene polymorphism and type I aortic dissection was examined in 205 unrelated hypertensives. A total of 94 patients underwent emergency repair due to type I aortic dissection, confirmed by computed tomography, and the remaining 111 were controls. Polymerase chain reaction was used to confirm that ACE gene polymorphism was due to insertion (I) or deletion (D) of a 287 base pair (bp) DNA sequence within intron 16. The genotype distribution and allele frequency of ACE I/D polymorphism between patients and controls were not statistically significant. When the frequency of at least one D allele carrier (DD or ID genotype) was compared with the II homozygous genotype, there was also no significant difference between the study groups. The findings revealed no association between ACE I/D polymorphism and aortic dissection. We conclude that I/D mutation of the ACE gene does not seem to be a risk factor for aortic dissection.
Introduction
Aortic dissection is one of the most potentially fatal conditions of the aorta. Its pathogenesis is said to involve both genetic and environmental factors, but this has not been clearly proven. Weakening of the aorta's media layers via micro-apoplexy of the vessel wall leads to higher wall stress, which can induce aortic dilatation and aneurysm formation, eventually resulting in intramural haemorrhage, aortic dissection or rupture. 1 Components of the renin-angiotensin system (RAS) are heavily expressed within vascular tissues, and up-regulation of local angiotensin II synthesis is associated with adverse autocrine effects on arterial structure and function, i.e. tissue RAS activity is a major determinant of vascular tone. 2 Angiotensin II promotes hypertension and alters shear stress. 3, 4 Experimental data suggest that activation of the RAS may lead to an increased inflammatory response in the vessel wall or to an activation of matrix metalloproteinase. 5, 6 One type of B Tangurek, B Ketenci, B Ozay et al.
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angiotensin-converting enzyme (ACE) gene polymorphism is created by the insertion (I allele) or deletion (D allele) of a 287 base pair (bp) DNA sequence within intron 16. 7 The DD genotype carriers have more ACE activity than the II genotype carriers in their cardiac tissue, plasma and lymphocytes. 8 -10 I/D polymorphism of ACE has been associated with coronary vascular tone 11 and the development of aneurysms. 12, 13 In addition, both angiotensin II-forming enzymes, chymase and ACE, are highly expressed in human aneurysmal aorta. 14 To the authors' knowledge, the I/D mutation of the ACE gene has not been examined before in aortic dissection, so this study aimed to investigate the subject.
Patients and methods

STUDY POPULATION
Unrelated hypertensive patients treated consecutively at Siyami Ersek Cardiovascular and Thoracic Surgery Centre, Training and Research Hospital, Istanbul were enrolled. Patients who underwent an emergency procedure due to aortic dissection were placed in the 'dissection group' and the remaining patients were regarded as controls. Aortic dissection was confirmed by computed tomography. The patients were diagnosed as hypertensive if their blood pressure was > 140/90 mmHg or if they were receiving any antihypertensive medication. Other risk factors for aortic dissection were also recorded (diabetes mellitus, dyslipidaemia, cigarette smoking). Patients were considered to have diabetes mellitus if their fasting glucose levels were > 126 mg/dl, if they had a previous diagnosis of diabetes, or a history of antidiabetic drug use. They were considered to be hypercholesterolaemic if their low-density lipoprotein (LDL) levels were > 130 mg/dl, and hypertriglyceridaemia was defined as triglyceride levels > 150 mg/dl or if they were receiving any antilipidaemic medications. The smoking status of the patients was recorded as smokers or non-smokers. Patients thought to have Marfan syndrome and those who were normotensive were excluded from the study.
The study protocol was approved by the ethics committee of Siyami Ersek Cardiovascular and Thoracic Surgery Centre, Training and Research Hospital, Istanbul. The patients or their families provided verbal consent to carry out the genetic testing.
GENETIC ANALYSIS
Polymerase chain reaction (PCR) was used for ACE genotyping. Genomic DNA was extracted from peripheral lymphocytes using the phenol-chloroform method. 15 The ACE I/D polymorphism was typed by PCR in a final reaction volume of 15 µl containing 100 ng genomic DNA, 3.0 mM MgCl 2 , 200 µM of each deoxynucleotide triphosphate, 300 nM primers flanking the insertion sequence, 140 nM nested primer, 4.7% dimethyl sulphoxide and 1.0 U of Taq polymerase (all reagents from Fermentas, St Leon-Rot, Germany). The PCR procedure used a thermal cycler (Techne™ Inc, Burlington, NJ, USA) protocol of one cycle at 94°C for 5 min, 58°C for 1 min and 72°C for 2 min, followed by 30 cycles each at 94°C for 1 min, 58°C for 1 min and 72°C for 2 min, and a final cycle at 94°C for 1 min, 58°C for 1 min and 72°C for 7 min. The PCR products were separated on 3.0% agarose gel and visualized under ultraviolet light after ethidium bromide staining.
STATISTICAL ANALYSIS
All statistical analysis was performed with SPSS ® version 11.5 (SPSS Inc, Chicago, IL, USA) for Windows ® and data were expressed as the mean ± SD. Comparison of the means Multivariate logistic regression analysis was used to assess independence of the risk factors on the occurrence of aortic dissection. A 95% confidence interval was used and Pvalues < 0.05 were considered to be statistically significant. Power analysis showed that for the study to achieve 80% power, a sample size of 143 patients was required.
Results
A total of 205 hypertensive individuals (92 males, 113 females, mean age 57 years, range 32 -83 years) were enrolled. Ninetyfour underwent emergency repair due to aortic dissection and the remaining 111 were controls, comparable for age and body mass index (BMI). Comparison of the demographic and clinical characteristics of the patients and controls is shown in Table 1 . Risk factors for aortic dissection other than hypertension (diabetes mellitus, dyslipidaemia, cigarette smoking) were significantly more prevalent in the dissection group. The difference in the proportion of males and females between the dissection and controls groups we believe was a random result of the individuals being selected consecutively for inclusion in the study since gender is not known to be an important determinant for aortic dissection. Since it is not a known risk factor, it was not included in the multivariate logistic regression analysis.
COMPARISON OF I/D MUTATION GENOTYPE DISTRIBUTION
The genotype distribution and allele frequency of the ACE I/D polymorphism were not significantly different between patients and controls and were in Hardy-Weinberg equilibrium ( Multivariate logistic regression analysis that adjusted for the D allele, dyslipidaemia, diabetes and smoking revealed that dyslipidaemia and smoking were independent risk factors for the development of aortic dissection (Table 3) . Dyslipidaemic individuals and smokers had a 2.9-fold (odds ratio [OR] 2.9, confidence interval [CI] 1.6 -5.4) (P = 0.001) and a 2.0-fold (OR 2.0, CI 1.0 -3.8) (P = 0.039) greater chance, respectively, of suffering aortic dissection. Although D allele carriers and diabetics were found to have a 1.3-fold (OR 1.3, CI 0.6 -3.0) and a 1.7-fold (OR 1.7, CI 0.9 -3.3) greater chance of suffering aortic dissection, respectively, these results were not statistically significant.
Discussion
Aortic dissection has high mortality and morbidity. Although several aetiological factors, such as congenital anomalies (Marfan syndrome, Noonan syndrome, Ehler-Danlos syndrome), 16 -19 cystic medial necrosis, hypertension, 20 -22 pregnancy, 17, 23 atherosclerosis, 17, 23 inflammatory diseases (giant cell arthritis, autoimmunity) 24 and trauma, 25 
TABLE 2: Genotype frequency and allele distribution of the angiotensin-converting enzyme gene insertion/deletion (I/D) mutation for aortic dissection patients and controls
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dissection, the issue has not been completely clarified and there has not been sufficient investigation of the genetic aspect. To the authors' knowledge, this is the first study investigating the relationship between aortic dissection and the ACE gene I/D polymorphism.
The mean age and BMI of the patients and controls in the present study were comparable, whereas other risk factors for aortic dissection (diabetes mellitus, dyslipidaemia, cigarette smoking) were significantly more prevalent in the dissection group.
It has been known that atherosclerosis is an aetiological factor for aortic dissection 17, 23 as in aortic aneurysms. 27, 28 Atherosclerotic risk factors, such as smoking and dyslipidaemia, are also defined as potential risk modulating conditions for aortic dissection. 1 Lee et al. 28 found atherosclerosis and smoking to be risk factors for aortic aneurysms; in addition, they found that smoking appears to have a direct effect on the risk of aortic aneurysm, which was independent of atherosclerosis. The present study's findings were consistent with the investigations described above; smoking and dyslipidaemia were found to be independent risk factors for aortic dissection.
Although the mechanism of action remains unclear, inflammatory processes 29 and proteases, such as metalloproteinase, 30 have been reported as causes of aortic aneurysm. Experimental data also suggest that activation of the RAS may lead to an increased inflammatory response in the vessel wall or to activation of matrix metalloproteinases. 5, 6 The I/D polymorphism of ACE has been associated with coronary vascular tone 11 and the development of aneurysms. 12, 13 In addition, angiotensin IIforming enzymes, chymase and ACE, are highly expressed in human aneurysmal aorta. 14 Higher ACE activity in cardiac tissue leads to higher angiotensin II levels and coronary artery disease. 31, 32 Atherosclerosis of the aortic wall also contributes to aneurysm formation. 27, 28 Patients with the DD genotype have high ACE levels in their plasma 9 and cardiac tissue. 10 This, in turn, increases the conversion of angiotensin I to angiotensin II, leading to a remodelling of vascular or cardiac tissue. It has been shown by a number of studies that angiotensin plays an important role in vascular remodelling 33 by stimulating the growth and migration of smooth muscle cells. 34, 35 Angiotensin II promotes hypertension and alters shear stress. 3, 4 Moreover, ACE is strongly expressed in active lesions, such as advanced atheromatous plaques. 36 Aortic aneurysms are characterized by the degradation of structural proteins, including both collagen and elastin. 37 -39 The degradation of collagen and elastin within the aortic wall has been attributed to an inflammatory response by T lymphocytes and macrophages, 40 -42 and to proteolytic enzymes released from macrophages and other cells. 29 Furthermore, the ACE DD genotype was reported to be associated with high ACE levels in human T lymphocytes. 43 There have been conflicting findings related to the relationship between abdominal aneurysms and ACE gene I/D polymorphisms. Fatini et al. 13 documented that the ACE DD genotype represents a susceptibility factor for abdominal aortic aneurysms. Pola et al. 12 reported identical results to Fatini et al. 13 and suggested a role for the ACE gene I/D polymorphism in the pathogenesis of abdominal aortic aneurysms in normotensive patients. In contrast, Hamano et al. 44 found no association between ACE I/D polymorphism and abdominal aortic aneurysms. Yeung et al. 45 also reported no correlation between abdominal aortic expansion rate and ACE I/D genotypes.
